Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35134850.
- Also identified by DOI 10.1093/cid/ciac086 and PMC identifier 9464068.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Anti-HIV Agents
- HIV Infections